GlaxoSmithKline PLC
LSE:GSK

Watchlist Manager
GlaxoSmithKline PLC Logo
GlaxoSmithKline PLC
LSE:GSK
Watchlist
Price: 1 342 GBX 2.48% Market Closed
Market Cap: 54.7B GBX
Have any thoughts about
GlaxoSmithKline PLC?
Write Note

Balance Sheet

Balance Sheet Decomposition
GlaxoSmithKline PLC

Current Assets 16.8B
Cash & Short-Term Investments 3B
Receivables 7.8B
Other Current Assets 6B
Non-Current Assets 41.3B
Long-Term Investments 1.2B
PP&E 9.8B
Intangibles 22.4B
Other Non-Current Assets 7.9B
Current Liabilities 20.3B
Accounts Payable 14.2B
Other Current Liabilities 6.1B
Non-Current Liabilities 23.3B
Long-Term Debt 13.6B
Other Non-Current Liabilities 9.8B

Balance Sheet
GlaxoSmithKline PLC

Rotate your device to view
Balance Sheet
Currency: GBP
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
1 313
1 114
1 462
826
569
795
1 762
1 427
879
2 746
Cash
1 313
1 114
1 462
826
569
795
1 762
1 427
879
748
Cash Equivalents
0
0
0
0
0
0
0
0
0
1 998
Short-Term Investments
3 094
4 791
3 524
3 085
3 389
3 991
4 608
2 908
6 998
2 246
Total Receivables
4 449
5 488
5 917
5 950
6 322
7 148
7 264
8 031
7 115
7 403
Accounts Receivables
3 556
3 879
4 679
4 693
5 185
5 494
5 562
6 261
5 473
5 976
Other Receivables
893
1 609
1 238
1 257
1 137
1 654
1 702
1 770
1 642
1 427
Inventory
4 231
4 716
5 102
5 557
5 476
5 947
5 996
5 783
5 146
5 498
Other Current Assets
1 591
478
706
489
1 171
1 610
617
525
631
751
Total Current Assets
14 678
16 587
16 711
15 907
16 927
19 491
20 247
18 674
20 769
18 644
PP&E Net
9 052
9 668
10 808
10 860
11 058
11 314
11 006
10 672
9 620
9 957
PP&E Gross
9 052
9 668
10 808
10 860
11 058
11 314
11 006
10 672
9 620
9 957
Accumulated Depreciation
10 303
11 082
11 356
10 859
11 430
11 251
11 307
10 846
10 518
10 259
Intangible Assets
8 320
16 672
18 776
17 562
17 202
30 955
29 824
30 079
14 318
14 768
Goodwill
3 724
5 162
5 965
5 734
5 789
10 562
10 597
10 552
7 046
6 811
Note Receivable
642
732
886
875
816
893
858
935
965
950
Long-Term Investments
1 454
1 462
1 248
1 101
1 558
2 151
3 424
2 214
1 541
1 192
Other Long-Term Assets
2 781
3 163
4 687
4 342
4 716
4 326
4 475
5 977
5 887
6 683
Other Assets
3 724
5 162
5 965
5 734
5 789
10 562
10 597
10 552
7 046
6 811
Total Assets
40 651
N/A
53 446
+31%
59 081
+11%
56 381
-5%
58 066
+3%
79 692
+37%
80 431
+1%
79 103
-2%
60 146
-24%
59 005
-2%
Liabilities
Accounts Payable
2 790
3 120
3 596
3 528
3 645
4 144
4 357
4 535
3 866
3 717
Accrued Liabilities
4 700
5 324
6 444
6 929
8 535
9 111
9 753
11 186
10 587
10 711
Short-Term Debt
2 915
435
1 426
765
4 420
5 020
1 145
802
1 639
1 006
Current Portion of Long-Term Debt
28
873
2 703
2 060
1 373
1 898
2 580
2 799
2 313
1 807
Other Current Liabilities
2 862
3 665
4 832
13 287
4 518
3 877
4 313
4 348
4 405
3 827
Total Current Liabilities
13 295
13 417
19 001
26 569
22 491
24 050
22 148
23 670
22 810
21 068
Long-Term Debt
15 841
15 324
14 661
14 264
20 271
23 590
23 425
20 572
17 035
15 205
Deferred Income Tax
445
1 522
1 934
1 396
1 156
3 810
3 600
3 556
289
311
Minority Interest
673
3 764
3 839
3 557
688
6 952
6 221
6 287
502
552
Other Liabilities
6 134
14 305
18 522
10 663
10 476
9 885
10 450
9 963
9 916
9 626
Total Liabilities
36 388
N/A
48 332
+33%
57 957
+20%
56 449
-3%
53 706
-5%
68 287
+27%
65 844
-4%
64 048
-3%
49 548
-23%
45 658
-8%
Equity
Common Stock
1 339
1 340
1 342
1 343
1 345
1 346
1 346
1 347
1 347
1 348
Retained Earnings
55
732
3 263
4 348
8
6 659
8 884
10 073
6 492
9 368
Additional Paid In Capital
2 759
2 831
2 954
3 019
3 091
3 174
3 281
3 301
3 440
3 451
Unrealized Security Profit/Loss
274
295
380
329
140
409
1 302
383
308
510
Other Equity
164
84
289
411
208
183
226
49
373
310
Total Equity
4 263
N/A
5 114
+20%
1 124
-78%
68
N/A
4 360
N/A
11 405
+162%
14 587
+28%
15 055
+3%
10 598
-30%
13 347
+26%
Total Liabilities & Equity
40 651
N/A
53 446
+31%
59 081
+11%
56 381
-5%
58 066
+3%
79 692
+37%
80 431
+1%
79 103
-2%
60 146
-24%
59 005
-2%
Shares Outstanding
Common Shares Outstanding
4 864
4 870
3 928
3 966
3 938
3 963
4 024
4 025
4 034
4 056

See Also

Discover More